Inactive Instrument

Ekso Bionics Holdings Inc Share Price Deutsche Boerse AG

Equities

US2826441030

Advanced Medical Equipment & Technology

End-of-day quote Deutsche Boerse AG
- EUR - Intraday chart for Ekso Bionics Holdings Inc

Financials

Sales 2024 * 20.52M 18.83M 1.58B Sales 2025 * 28.1M 25.78M 2.17B Capitalization 24.9M 22.84M 1.92B
Net income 2024 * -9M -8.26M -694M Net income 2025 * -4M -3.67M -309M EV / Sales 2024 * 1.21 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.89 x
P/E ratio 2024 *
-2.66 x
P/E ratio 2025 *
-5.71 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.79%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 54 31/03/21
Director of Finance/CFO 50 30/04/17
Chief Operating Officer 52 -
Members of the board TitleAgeSince
Director/Board Member 56 24/12/21
Director/Board Member 69 28/12/20
Director/Board Member 39 10/03/18
More insiders
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
More about the company